Design And Synthesis Of 3-Arylcoumerin Derivatives As A Selective Mao-B Inhibitor. Journal of Pharmaceutical Negative Results, [S. l.], p. 9820–9833, 2022. DOI: 10.47750/pnr.2022.13.S09.1147. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/6828.. Acesso em: 30 jun. 2026.